Medicare Access and CHIP Reauthorization Act

A2C Medical Customers Achieve Top Performance MIPS Score for the 2021 Payment Year

Retrieved on: 
Wednesday, March 31, 2021

BIRMINGHAM, Ala., March 31, 2021 /PRNewswire/ -- A2C, a comprehensive electronic medical record (EMR) solution built for physical, speech and occupational therapists, today announced its EMR users have achieved a MIPS score of 94.9 out of 100 for the 2021 payment year.

Key Points: 
  • BIRMINGHAM, Ala., March 31, 2021 /PRNewswire/ -- A2C, a comprehensive electronic medical record (EMR) solution built for physical, speech and occupational therapists, today announced its EMR users have achieved a MIPS score of 94.9 out of 100 for the 2021 payment year.
  • MIPS, or the Merit-Based Incentive Payment System, was created under the Medicare Access and CHIP Reauthorization Act of 2015 and is a value-based payment model.
  • Physical rehabilitation only participates in Quality Measures and Improvement Activities and is exempt from the Promoting Interoperability and Cost components of MIPS.
  • A2C Medical was the answer to a need for a comprehensive practice management solution for Adam's wife and physical therapy clinic owner, Dena Aitken.

McKesson Approved as QCDR for 2021 MIPS Program Year

Retrieved on: 
Thursday, March 25, 2021

For the fifth consecutive year, McKesson has received approval from The Centers for Medicare & Medicaid Services (CMS) to participate in the Merit-based Incentive Payment System (MIPS) as a Qualified Clinical Data Registry (QCDR).

Key Points: 
  • For the fifth consecutive year, McKesson has received approval from The Centers for Medicare & Medicaid Services (CMS) to participate in the Merit-based Incentive Payment System (MIPS) as a Qualified Clinical Data Registry (QCDR).
  • In addition, CMS approved all eight of the custom QCDR measures developed by The US Oncology Network and submitted as part of McKessons 2021 application, confirming the importance of these measures to the quality and integrity of oncology care.
  • Its also important to limit the number of measures in the MIPS program to ease the reporting burden on clinicians and reduce the overall cost of care.
  • The Network provides practices with access to coordinated resources, best business practices, and the experience, infrastructure and support of McKesson Corporation .

Nebraska Health Information Initiative (NEHII) recognized as CMS Submitter for Quality Payment Program for 2021

Retrieved on: 
Monday, December 21, 2020

OMAHA, Neb., Dec. 21, 2020 /PRNewswire/ -- Nebraska Health Information Initiative (NEHII) is pleased to announce that the Centers for Medicare and Medicaid Services (CMS) recognized NEHII as a Qualified Clinical Data Registry (QCDR) for 2021.

Key Points: 
  • OMAHA, Neb., Dec. 21, 2020 /PRNewswire/ -- Nebraska Health Information Initiative (NEHII) is pleased to announce that the Centers for Medicare and Medicaid Services (CMS) recognized NEHII as a Qualified Clinical Data Registry (QCDR) for 2021.
  • QCDRs are one of several available reporting mechanisms for eligible clinicians and groups for the Merit-Based Incentive Payment System (MIPS), Primary Care First (PCF) and other CMS Quality Payment Program (QPP) payment models.
  • NEHII's mission is to bring trust and value to health information technology by creating solutions for moving health data forward.
  • NEHII is the designated statewide Health Information Exchange designed to share clinical and administrative data among providers in Nebraska and neighboring states.

501 Health Care Practices Across the Country Urge Congress to Act to Protect Value-Based Care Incentives

Retrieved on: 
Wednesday, December 2, 2020

Congress enacted legislation the bipartisan Medicare Access and CHIP Reauthorization Act (MACRA) established an incentive payment for providers who participate in Advanced Alternative Payment Models (APMs).

Key Points: 
  • Congress enacted legislation the bipartisan Medicare Access and CHIP Reauthorization Act (MACRA) established an incentive payment for providers who participate in Advanced Alternative Payment Models (APMs).
  • The law included a five percent Medicare bonus intended to accelerate the transformation away from fee-for-service, volume-based reimbursement.
  • This funding helps clinicians continue to build on the success of these models, driving further innovation that benefits patients.
  • "For them to miss out on their bonus opportunity would go against the intent of MACRA and its value-based care incentives."